The global hypopigmentation disorder treatment market is anticipated to reach a CAGR over 5.6% during the forecast period. Hypopigmentation is a skin condition, where the skin looses the color or skin pigments due to decrease in melanin or melanocyte. The formation of pigmented skins may occur in patches or all over the body. Although, hypopigmentation may occur among people of all races, but the occurrence of such a condition is more noticeable among individuals with dark complexion. Market Industry Reports (MIR) has published a new report titled "Hypopigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global hypopigmentation disorders treatment market is anticipated to witness a substantial CAGR of 5.6% in the forecast period.
Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030.
Major Key Players of the Hypopigmentation Disorders Treatment Market are:
ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, RXi Pharmaceuticals, Obagi Cosmeceuticals, and Alvogen among others
Read More @ http://www.sbwire.com/press-releases/hypopigmentation-disorders-treatment-market-to-witness-growth-acceleration-during-2019-2030-allergan-skinceuticals-pierre-fabre-1279007.htm
Read More @ http://www.sbwire.com/press-releases/hypopigmentation-disorders-treatment-market-to-witness-growth-acceleration-during-2019-2030-allergan-skinceuticals-pierre-fabre-1279007.htm
Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030.
Major Key Players of the Hypopigmentation Disorders Treatment Market are:
ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, RXi Pharmaceuticals, Obagi Cosmeceuticals, and Alvogen among others
Read More @ http://www.sbwire.com/press-releases/hypopigmentation-disorders-treatment-market-to-witness-growth-acceleration-during-2019-2030-allergan-skinceuticals-pierre-fabre-1279007.htm
According to the American Academy of Dermatology, vitiligo is considered to be among 24 skin diseases, which are widely prevalent among the population. Vitiligo is known to affect individuals from all ethnic background and genders equivalently. While, vitiligo can affect people from all ages, but the prevalence of the same is more prominent among individuals between the age 10 and 30 years. Moreover, in 2013, it was estimated that more than 150,000 Americans from all age groups underwent treatment for vitiligo. Rising incidences and prevalence of vitiligo is anticipated to further contribute to the growing demand of the global hypopigmentation disorders treatment market.
Major Types of Hypopigmentation Disorders Treatment Market covered are:
Topical Drugs
Chemical Peels
Laser Therapy, and Microdermabrasion
Major Applications of Hypopigmentation Disorders Treatment Market covered are:
Dermatology Centers
Aesthetic Clinics, and Hospitals
Major Types of Hypopigmentation Disorders Treatment Market covered are:
Topical Drugs
Chemical Peels
Laser Therapy, and Microdermabrasion
Major Applications of Hypopigmentation Disorders Treatment Market covered are:
Dermatology Centers
Aesthetic Clinics, and Hospitals
No comments:
Post a Comment